Quantcast

Latest Regenerative medicine Stories

2014-06-11 23:07:57

Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has been recruited to lead a newly established Institute of Cellular Therapeutics based at Allegheny General Hospital (AGH). Pittsburgh, PA (PRWEB) June 11, 2014 Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has...

2014-06-11 23:02:03

Innovator to join Organovo CEO in session about breakthrough technology. WASHINGTON (PRWEB) June 11, 2014 In an era in which clinical studies take years to complete and testing a single drug can cost millions, technology that once seemed far-fetched — growing models of human organs on microchip — is making remarkable strides. Creating models of human organs on microchips can save the industry time and money and reduce the need for testing on animals and even patients themselves....

2014-06-05 23:04:48

OMICS Publishing Group takes pleasure in announcing the 3rd International Conference on Tissue Science and Regenerative Medicine during September 24-26, 2014 at Valencia, Spain with an aim to promote Breakthrough Strategies for Tissue Engineering, Repair & Regeneration. Los Angeles, CA (PRWEB) June 05, 2014 The main target of Tissue Science-2014 is to offer tantalizing hope for the repair and replacement of damaged organs and tissues, with the ultimate goal of restoring normal tissue...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...

2014-06-02 08:31:56

SACRAMENTO, Calif., June 2, 2014 /PRNewswire/ -- SynGen Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that Dr. William Gerber has been appointed CEO to replace co-founder and lead inventor Philip Coelho. Mr. Coelho, who will become the Chief Technical Officer (CTO) of SynGen, noted "Bud Barry, my business partner and...

2014-06-02 08:29:08

On August 1, 2013 The Company issued 75,000,000 million shares as part of a venture to open restaurants in association with South Of The Border Holdings, Inc.; 70 Million have been canceled and returned to the company treasury. SARASOTA, Fla., June ­­2, 2014 /PRNewswire/ -- Caribbean International Holdings (OTC: CIHN) announced today that 70 million of the 75 million shares issued by the Company as part of a venture in association with South Of The Border Holdings, has been...

2014-05-30 16:24:52

SARASOTA, Fla., May 30, 2014 /PRNewswire-iReach/ -- On Friday, April 18(th) PGFX Patent Holdings, operating as Heritage Biosciences, LLC made an asset acquisition of proprietary methods, devices and intellectual property from Orogen Biosciences, Inc. Orogen, based out of Sarasota, Florida, was an early innovator in processing platelet rich plasma (PRP) and concentrating growth factors, cytokines, proteins and adhesion molecules to optimize the most effective and efficient methods for...

2014-05-29 08:30:21

SAN DIEGO, May 29, 2014 /PRNewswire/ -- ViaCyte, Inc., a regenerative medicine company focused on developing a cell replacement therapy for the treatment of patients with insulin-dependent diabetes, announced today that the Company has settled a patent dispute involving certain of the Company's definitive endoderm patents and patent applications. The dispute involved an appeal to the U.S. District Court by Asterias Biotherapeutics, Inc., (as assignee of Geron Corporation), which...

2014-05-22 23:09:01

Patients now have the opportunity to receive Regenerative Medicine services at Healthpointe. La Mirada, CA (PRWEB) May 22, 2014 Healthpointe Medical Group is proud to announce that they are offering Regenerative Medicine Services at their facilities located throughout Southern California. Regenerative Medicine is a rapidly growing field that is aimed at restoring and/or replenishing the normal function of tissues that are damaged or otherwise affected by diseases. Through this program,...

2014-05-16 08:27:03

/PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) CEO and President, Richard Garr, will present at the World Stem Cells & Regenerative Medicine Congress, on Thursday, May 22, at 11:35 a.m. BST in London, UK (http://www.terrapinn.com/conference/stem-cells/index.stm). Neuralstem is currently in a Phase II clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) with its NSI-566 stem cells and has been approved to commence a Phase I study in spinal cord...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related